Evaluation of candidate International Standards for meningococcal capsular polysaccharide groups W and Y

2024-8-1

Current trends in development and manufacturing of higher-valent pneumococcal polysaccharide conjugate vaccine and its challenges

2024-8-1

Risk management for viral clearance: A case study on adoption of platform validation approach and risk management of process changes

2024-8-1

From discovery to innovation in animal health: Maturing emerging technologies for industrial development

2024-8-1

It is time to reconsider the use of naturally-occurring endotoxins in endotoxin recovery studies: Part 2 of a BioPhorum harmonized endotoxin recovery study

2024-8-1

A species-independent indirect-ELISA for detection of antibodies to the non-structural protein 2B of foot-and-mouth disease virus

2024-8-1

Aims and Scope/Editorial Board/Publishing Details

2024-8-1

Designing multi-epitope vaccine against human cytomegalovirus integrating pan-genome and reverse vaccinology pipelines

2024-7-13

COVID-19: A case for plasma derived natural anticoagulants?

2024-6-25

Aims and Scope/Editorial Board/Publishing Details

2024-5-1

Comparison of skeletal muscle decellularization protocols and recellularization with adipose-derived stem cells for tissue engineering

2024-5-1

From eradication to re-emergence: The changing landscape of polio in the cVDPV2 era

2024-5-1

Circulation of yellow fever virus in Benin city, Edo state Nigeria

2024-5-1

Animal cell substrates for the production of biologicals: An introduction to WHO documents

2024-5-1

Maintaining the quality of vaccines through the use of standards: Current challenges and future opportunities

2024-5-1

Report of a collaborative study to establish the first Indian Pharmacopoeia reference standard for teriparatide

2024-5-1

An indirect ELISA for detecting anti-SARS-CoV-2 antibodies in human sera using a baculovirus-expressed recombinant nucleocapsid antigen

2024-5-1

Overview of regulatory frameworks on the national lot release of plasma-derived medicinal products in Korea

2024-5-1

Standards for fecal microbiota transplant: Tools and therapeutic advances

2024-5-1

pH inactivation of SARS-CoV-2 and SARS-CoV in virus spiked protein A eluates from a mAb purification process

2024-5-1

Design and computational evaluation of a novel multi-epitope hybrid vaccine against monkeypox virus: Potential targets and immunogenicity assessment for pandemic preparedness

2024-5-1

Validation of a next generation sequencing method for adventitious virus detection: Demonstration of sensitivity in multiple cell lines

2024-5-1

Prevalence of viral agents causing swine reproductive failure in Korea and the development of multiplex real-time PCR and RT-PCR assays

2024-4-1

Outer membrane vesicles as nanovaccine candidates against pathogenic Leptospira in experimental Guinea pig model

2024-3-26

Ethical approval for controlled human infectious model clinical trial protocols – A workshop report

2024-2-1

Fourth Controlled Human Infection Model (CHIM) meeting – CHIMs in endemic countries, May 22–23, 2023

2024-2-1

Enabling the evaluation of COVID-19 vaccines with correlates of protection

2024-2-1

Molecular characterization of Anaplasma ovis Msp4 protein in strains isolated from ticks in Turkey: A multi-epitope synthetic vaccine antigen design against Anaplasma ovis using immunoinformatic tools

2024-2-1

Development of an ELISA for the detection of fowl adenovirus serotype −4 utilizing fiber protein

2024-2-1

The current status of the biosimilars landscape in China

2024-2-1

A validated polyclonal antiserum-based immunoassay for assessment of HPV 16 L1 relative potency

2024-2-1

Fifty years of advancing biologicals and beyond

2024-2-1

Nanoparticle formulation for the development of a dog nanovaccine against Cystic Echinococcosis

2024-2-1

Regulatory workshop on challenge strain development and GMP manufacture – A stakeholder meeting report

2024-2-1

Efficient extraction of adventitious virus nucleic acid using commercially available methods

2024-2-1

Report for the Eighth Asian National Control Laboratory Network meeting in 2023: Self-sufficiency strategy of plasma-derived medicinal products and regulatory harmonisation

2024-2-1

Evaluation of next-generation sequencing performance for in vitro detection of viruses in biological products

2024-2-1

An antibody-free evaluation of an mRNA COVID-19 vaccine

2024-2-1

Adjuvant effects of novel water/oil emulsion formulations on immune responses against infectious bronchitis (IB) vaccine in mice

2024-2-1

Expression and purification of Hepatitis B virus core antigen using Escherichia coli and its utilization for the diagnosis of Hepatitis B virus infections

2024-2-1

Nano-emulsion encapsulation for the efficient delivery of bacteriophage therapeutics

2024-2-1

A rapid and simple sterility test method based on solid culture medium containing blood

2024-2-1

Viral clearance capability of monoclonal antibody purification

2024-2-1

Novel vaccine candidates of Bordetella pertussis identified by reverse vaccinology

2024-2-1

Aims and Scope/Editorial Board/Publishing Details

2024-2-1

The role of real-world evidence for regulatory and public health decision-making for Accelerated Vaccine Deployment- a meeting report

2024-2-1

Fourth Controlled Human Infection Model (CHIM) meeting, CHIM regulatory issues, May 24, 2023

2024-2-1

Adjuvant effects of novel water/oil emulsion formulations on immune responses against infectious bronchitis (IB) vaccine in mice

2023-12-14

Fifty years of advancing biologicals and beyond

2023-11-21

Expression and purification of Hepatitis B virus core antigen using Escherichia coli and its utilization for the diagnosis of Hepatitis B virus infections

2023-11-16